This amendment provides $303,650 the first year and $648,000 the second year from the general fund and three positions for the fiscal impact of legislation passed during the 2024 Regular Session, which establishes the Prescription Drug Affordability Board for the purpose of identifying high cost prescription drugs, reviewing pricing and cost information, conducting affordability reviews of selected prescription drug products, and if necessary, setting an upper payment limit, which shall apply to all purchases and payer reimbursements for the product dispensed in the Commonwealth.